(R)-1-(5-Bromopyridin-3-yl)ethanamine, 97.0%, 1g

Tris(3-idrossipropiltriazolilmetil)ammina, minimo 95%, 100 mg, confezione in plastica.

Ethyl 2-(2-hydroxyphenyl)acetate, 95.0%, 5g

methyl 5-cyano-2-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate, 98%, 250mg

(4-(Pyridin-2-yl)phenyl)methanamine dihydrochloride, 97%, 5g

Methyl 2-hydroxy-5-(hydroxymethyl)benzoate, 97%, 100mg

Pamoic Acid Disodium Salt Monohydrate>98.0%(HPLC)250g

((3aR,4R,6R,6aR)-6-(2,6-Dichloro-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol, 97%, 250mg

tert-Butyl 1H-pyrazolo[3,4-b]pyridine-3-carboxylate, 97%, 250mg

N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-ethanamine, 95.0%, 2g

(S)-1-Boc-Azetidine-2-carboxylic acid, 97.0%, 1g

Ossido di manganese(IV) in polvere 99,9% 250 g

N-Ethylpropionamide>99.0%(GC)25g